Cleared Traditional

K163475 - iVue
(FDA 510(k) Clearance)

K163475 · Optovue, Inc. · Ophthalmic
Jun 2017
Decision
179d
Days
Class 2
Risk

K163475 is an FDA 510(k) clearance for the iVue. This device is classified as a Tomography, Optical Coherence (Class II — Special Controls, product code OBO).

Submitted by Optovue, Inc. (Fremont, US). The FDA issued a Cleared decision on June 9, 2017, 179 days after receiving the submission on December 12, 2016.

This device falls under the Ophthalmic FDA review panel. Regulated under 21 CFR 886.1570. Viewing, Imaging, Measurement, And Analysis Of Ocular Structures. Diagnostic Device To Aid In The Detection And Management Of Various Ocular Diseases..

Submission Details

510(k) Number K163475 FDA.gov
FDA Decision Cleared SESE
Date Received December 12, 2016
Decision Date June 09, 2017
Days to Decision 179 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF

Device Classification

Product Code OBO — Tomography, Optical Coherence
Device Class Class II — Special Controls
CFR Regulation 21 CFR 886.1570
Definition Viewing, Imaging, Measurement, And Analysis Of Ocular Structures. Diagnostic Device To Aid In The Detection And Management Of Various Ocular Diseases.

Similar Devices — OBO Tomography, Optical Coherence

All 64
UNITY DX (UDX)
K252633 · Cylite Pty. , Ltd. · Dec 2025
Tomey Cornea/Anterior Segment OCT (CASIA2)
K250553 · Tomey Corporation · Jul 2025
SPECTRALIS HRA+OCT and variants
K250868 · Heidelberg Engineering GmbH · May 2025
Anterion
K240924 · Heidelberg Engineering GmbH · Dec 2024
SPECTRALIS with Flex Module
K241163 · Heidelberg Engineering GmbH · Oct 2024
3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1 (type: Maestro2); IMAGEnet6 Ophthalmic Data System
K241081 · Topcon Corporation · Jul 2024